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Offering financial incentives to achieve medication adherence in patients with severe mental illness has been controversially discussed.
Aims
To explore the views of different stakeholders on the acceptability of the practice 
Method
Focus group study consisting of 25 groups with different stakeholders
Results 
Eleven themes dominated the discussions and fell into four categories: 1) ‘Wider concerns’ including the value of medication; source of funding; how patients would use the money, and a presumed government agenda behind the idea. 2) ‘Problems requiring clear policies’ comprising of practicalities and assurance that incentives are only one part of a tool kit. 3) ‘Challenges for research and experience’ including effectiveness; the possibility of perverse incentives; and impact on the therapeutic relationship. 4) ‘Inherent dilemmas’ around fairness; and potential coercion. 
Conclusions              
The use of financial incentives is likely to raise similar concerns in most stakeholders, only some of which can be addressed by empirical research and clear policies. 
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Maintenance antipsychotic medication has been shown to be effective in the treatment of patients with schizophrenia, schizo-affective psychosis, and bipolar disorders. It is unequivocally recommended by the National Institute for Clinical Excellence (NICE) guidelines,​[1]​ yet, adherence to medication remains problematic. Several strategies (e.g. compliance therapy, psychotherapy, family education, telephone prompting and psycho-education) have been tested to improve adherence, however studies show that they have at best, a limited effect.​[2]​ ​[3]​ Non-adherence to medication is a particular problem in a group of patients with psychotic disorders receiving care by mental health teams in the community. Hospital re-admission,​[4]​ social withdrawal, low quality of life and disruptive or self-harming behaviour​[5]​ have been identified as some of the possible consequences of non-adherence to medication as highlighted by various reports of serious untoward incident inquiries. In an analysis of serious untoward incidents in England,5 it was noted that non-adherence to treatment is a feature of at least a quarter of suicides and homicides by people with mental illness. New strategies are therefore required to achieve medication adherence in some patients with psychotic disorders. Evidence from the United States demonstrates that financial incentives can substantially improve adherence to treatment in various medical conditions.6 However, there is very little literature on their use to achieve medication adherence in patients with psychotic disorders. Out of five cases in East London7, four accepted financial incentives and had improved medication adherence with favourable clinical outcomes. The incentives were offered to patients where adherence had not been achieved by any other means.









Staff and patients from community mental health teams and assertive outreach teams from three Mental Health Trusts (East London Foundation NHS Trust, North East London Foundation NHS Trust and Hampshire Partnership NHS Trust) were recruited to one of 18 focus groups. The three Trusts cover inner-city, suburban and more rural areas with different levels of deprivation including culturally diverse London Boroughs with high morbidity levels. One group consisted of non-executive directors of a Mental Health Trust. A further four groups were recruited by the national mental health charity organisation Rethink (Three carers groups and one group with voluntary organisation representatives). One group was conducted with patient forum representatives and one with health economists from the London School of Economics and Kings College London.
  
Consultant psychiatrists and trainee psychiatrists were identified through staff lists and invited to the groups. For the recruitment of other staff, we approached 18 community mental health teams and 9 assertive outreach teams. A total of 18 teams expressed an interest in participating. We presented the aims of the project at existing team meetings, at which point, two teams declined participation and therefore did not submit staff contact details; however one of them agreed to take part in a multidisciplinary focus group. Staff names and contact details from the manager of each remaining team were obtained from the team managers. An invitation to participate in a focus group was then sent to staff via email and followed up with a telephone call after 5 working days if no response was received. Service users were approached by staff and/or team managers from the community and assertive outreach teams to participate in one of two focus groups while a third group were recruited through their links with a patient forum. 

Procedure and data collection















Although groups varied substantially in their atmosphere, exact discourse and aspects of the argument, there was a high level of saturation regarding the content of the concerns raised. Practically all of the major themes were brought up in every group. 

The transcriptions generated a total of 23 codes which guided and informed further analysis and identification of 11 major themes describing the key discussion threads of the groups. Themes fell into one of four main categories depending on the nature of the concern and the possibilities to address and further explore them. The categories consisted of ‘wider concerns’, ‘problems requiring policies’, ‘challenges for research and experience’, and ‘inherent dilemmas’. The categorisation did not consider how serious, important or complex the themes were. The focus groups, the four categories of themes, and all themes with illustrating quotes are summarised in figure 1.






Four major themes reflected wider concerns that were linked to the issue of financial incentives. These themes went beyond the specific clinical problem and concerned more general issues associated with it. 

There were some very critical views on the value of medication in psychiatric treatment, expressed with particular intensity by psychologists and some patients. They felt that medication as such should be prescribed and used with more caution, if at all and that a ‘medical model’ was too dominant in mental health care. 

The question as to where the money for the provision of incentives would come from led to concerns that other important services and interventions might suffer financially if money is spent on incentivising patients. 

Further concerns were raised that patients may use the money to buy drugs and alcohol which may then have a negative impact on their mental health. Some participants thought that if it could be ensured that the money was used for therapeutic purposes, such as accessing recreational activities, then such a practice would be more acceptable.

Finally, there were repeated assumptions, particularly in non-clinician groups, that the idea of offering financial incentives was brought up by the ‘state’ or more specifically the ‘government’ to control patients and save money by reducing alternative services. Whilst the term ‘government’ directly featured in 15 groups, only one participant supposed an interest of pharmaceutical companies as a potential driver.





Two major themes addressed issues that would require further clarification by precise policies. 

Many participants raised questions about the practicalities of offering financial incentives and the feasibility of such practice. They wondered how the incentives would be administered, how the reception of money would impact on benefit schemes, and over what period of time the incentives should be used. 

If the financial incentives were seen as a reasonable option and ‘part of a (clinician’s) tool kit’, there was still an emphasis that safeguards have to be in place to ensure that it is used only as a ‘last resort’ when all other efforts to achieve adherence have failed. It should not become an ‘easy option’ or be used as a tool to side-step support that was perceived as more time consuming. There was a consensus that every attempt should be made to understand why a patient has stopped taking medication so that options for alternative interventions can be explored.
 
Challenges for evidence and experience 

Three themes concerned issues that may, at least in theory, receive some clarification through evidence from research and clinical experience. Whilst some of the issues may be addressed in conventional trials, others may be more difficult to study.

Participants frequently wondered whether the practice would work and indeed lead to higher medication adherence. Many participants welcomed the idea of further research to establish the effectiveness of the scheme and stated that this was the most important factor in determining the acceptability of offering financial incentives. Others dismissed this as a non-starter and were opposed regardless of the potential effectiveness arguing that they could not see how it would work in practice or that it was wrong for reasons captured in other themes of the analysis. 

Similarly, concerns were raised that offering financial incentives to those who were non-adherent could have a negative impact on those who were medication adherent, with the potential to encourage non adherence in order to obtain money. Particularly participants with less direct and personal experience of community mental health care of psychotic disorders, either as patients or clinicians, argued that the offer of money may encourage false reporting of ill health, and conversely a reluctance to report side effects and negative consequences of taking medication to clinicians in case payments were withdrawn. 





This fourth category contains two themes that appear inherently linked with offering financial incentives to achieve medication adherence in patients with psychotic disorders and cannot be clarified through policies or research. 

Financial incentives were seen as a ‘powerful tool’ in enabling behavioural change. Some stakeholders felt ‘uncomfortable’ at the thought of using money in therapeutic practice, particularly as it targeted the poor and could be used to influence decisions of vulnerable people. Some participants suggested that the use of incentives other than money would feel more comfortable, with vouchers being a popular alternative. A core issue was whether the introduction of money would motivate patients to make decisions that may go against their beliefs as to what is right for them. It was felt that patients may proceed to take the medication even though they may be faced with intolerable side effects. Some participants however saw money for medication as more of a reward or ‘compensation’ for having to put up with side effects, while others emphasised that service users still had a choice over whether to take the money and therefore take the medication. This led to the question of who would be responsible for the patient’s decision in such a situation and for potential negative long term effects of the medication. In this context financial incentives were potentially coercive. Views were inconsistent as to whether such a form of ‘coercion’ would be preferable to formal methods of compulsory treatment using the Mental Health Act. Mainly clinicians argued that in practice many other methods of covert coercion and indirect material incentives, such as invitations to lunch or help with filling in forms to get benefits, are routinely used to encourage medication and do not draw criticism. 






The study shows what issues are likely to be raised, whenever financial incentives to achieve medication adherence in non-adherent patients with psychotic disorders are discussed. All stakeholder groups covered most of the same discussion threads albeit with different emphasis and arguments, however there were no clear differences between groups. The concerns expressed in the 11 themes may be well founded or irrational, but need to be addressed whenever a wider application of the practice is considered. 

Strengths of the study are that very different stakeholder groups were included, saturation was reached, and the results appear plausible as a criterion of validity. Weaknesses are the general limitations of the focus group methodology and the fact that very few participants had any experience with using financial incentives so that most concerns had a speculative nature. 

The debate in the groups raised wider issues and specific concerns, which to some extent reflect a suspicion that offering financial incentives might not only be a desperate attempt of clinicians to help patients with whom all other means have failed, but that there are improper motives and even a government agenda behind it. One can only speculate whether this is influenced by the public nature of the NHS, the way it has been run using top down initiatives, and the general politicising of health service issues in the United Kingdom. 

Whether offering financial incentives are an acceptable option or not, is an issue for an ethical debate, and the findings of this study can inform such a debate. Beauchamp12 suggested four ethical principles to consider health care interventions, i.e. autonomy, beneficence, non-maleficence, and justice.

Each of these principles has been addressed by the results. The autonomy of the patient might be affected through a coercive effect of financial incentives with unclear responsibilities for potentially harmful medication effects, especially in the long run. 

Beneficence overlaps with the issue of effectiveness, but is also linked to the frequently discussed question as to whether offering financial incentives is in the interest of the individual patient or the public at large. Ethically, only the former might be seen as a justification to implement the practice in a voluntary treatment setting. Additionally, capacity to make the decision and provide informed consent would be required.

Several aspects concerned non-maleficence, referring to potential harm.  This may affect patients on such a scheme through the withholding of time consuming alternative methods, more complicated relationships with their clinicians, more negative attitudes towards medication, or the harmful use of the money for drugs. It may also affect other patients who might become non-adherent to become eligible for the financial incentives. 

The issue of justice was directly mentioned as some participants found it unfair that some patients received money to take medication and others did not. Such a position may be challenged by arguing that resources for health interventions need to be distributed following the needs of the individual concerned. 
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Text box 1. Case vignette used to stimulate focus group discussions





































Figure 1. Focus groups, categories, emerging themes and illustrating quotes
































Non-executive directors (1 group)


















“you don’t want to take the medication but I’m gonna play to something that you cannot refuse because you really need this £50 so….” (Psychiatrist in training)


Effects on the therapeutic relationship (18 groups)
“it’s about having a collaborative relationship, not one having more control over the other...” (Social worker)


Perverse incentive (24 groups)




“It doesn’t really make sense if everything else has been tried what’s to say that paying them is gonna make them take the medication anyway…” (user representative)


Part of toolkit (24 groups)




“how much money do you mean and how often would you be giving it to them?” (Carer)


Government agenda (15 groups)
“I’d think it’s politically driven, I do think there is definitely a government agenda…” (Team manager)


Use to which incentive is put (20 groups)
“They can go out and buy drugs, they can go out and …I don’t know….” (Health economist)


Opportunity cost (16 groups)





Value of medication ( 21 groups)
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Text boxes with quotes illustrating each themeThemeFocus groupQuoteWider Concerns    Value of medicationConsultants (FG4)(F4P7) “for me is unethical because that patient may not benefit from that medication and we know that many patients do not benefit from that medication and even in the …..even in the……ehm…… situation where there is historical response to medication…that is not an absolute predictor of future response to medication.”Psychologists (FG9) (F9P3) “I suppose the other thing was there is an assumption that actually medicating somebody does reduce their risk and I’ve worked on wards and people are usually quite happily sort of medicated. But I would say still there is quite high instance of serious incidents”Voluntary organisations (FG6)(F6P6) “It should only be offered for as long as it is considered clinically, the medication is the right thing to give I mean you know you wouldn’t have someone on medication if you don’t think they should be on medication so presumably you are only talking about people who you think will benefit at that point in time from receiving medication”User Forum (FG15)(F15P4) “I think as well it’s focusing on the sort of medication being the be all and end all cos if you’re concentrating on paying for people to take their medication you’re placing less of an emphasis on the other support services so people are gonna think oh well you know I’m gonna go and get a sort of certain amount of money I’ll just take my medication and not engage in other services”(dominant medical model)Junior doctors (FG5)(F5P3)  “and I think that kind of goes into the whole doing this kind of says medication is the complete be all and end all of psychiatric management and it isn’t unless ….yeah you could be getting their meds in but are you going to be able to get them to engage in anything else?”Social workers (FG12)(F12P5) “all I see is the medical model being pushed forward, that’s all I can see and just…it’s just…it’s there already but it’s just been…by paying people just reinforce it”Opportunity costCarers(FG16 and FG22)(F16P12) “who’s the provider of the money? Is it the national health…”(F22P6)“I mean, put all the money that you are gonna contemplate paying people to take medication in CBT, cos that’s what our son needs, you can’t get it, you know, it’s not available it’s, you know, …and we’re doing that for our son, as carers when really it should be the mental health service doing it, so yeah more money for training for people to do CBT yeah”Junior doctors (FG5)F5P2 “and if there’s also …….resources are being diverted from inpatient care to paying these people in the community to take their depots then you know it’s just gonna get worse and there will be fewer funds available to look after people in inpatient settings”Non-executive directors (FG3)(F3P3) “you‘ll be paying an awful lot of people anyway who would take the medication without being paid so that’s a waste of resource that could be spent better on other things in the health service”Service users (FG19) (F19P4) “it could go to staffing of care, it could go to doctors on call, er it could be spent in another sector of the community rather than at the patients who might not really should be paid”Use to which incentive is put (money to buy drugs/ alcohol)Consultants (FG17)(F17P5) “I mean cash is clearly problematic in a kernel of the population that have such high prevalence of drug and alcohol use, cigarette smoking, so if we’re doing something we should be promoting health and…so that would be one particular issue”Health economists (FG7) (F7P5) “They can go out and buy drugs, they can go out and …I don’t know….all sort of things can come to mind. So, to the extent that there are some negative externalities with giving people financial incentives indirectly” (people can spend money anyway they want) Nurses (FG8)(F8P3) “and ok there is the argument that such money the client might use it like my colleagues said go on and use it on crack or whatever, if a client wants to get money he will get the money, whether we give him the 10 pounds or not.”(access to other services)Service users (FG11)(F11P8) “with this one we don’t want the money you know? These people you can put them and arrange trips for them, like to the seaside, to go a day out or you know for 3 days, or for a week, you know, twice or three times a year, you know, for them…it is good for them you know, to smell a bit of fresh air, to see best view of the seaside, or the countryside, you know, it is good for their mental health, you know, not the money, it’s well organised trips for the users to go out, it’s good for them, and mentally and physically, two things”(F11P4) “I personally would rather see money be put in to services and people being supported to take medication”Non-executive directors (FG3)(F3P3) “if you’re gonna pay some you can’t pay some and not others so you’d be spending money on just about everyone to, paying them, bribing them to take their medication, then you haven’t got the money to pay for nurses and other people who might support them in the community and encourage them to”(F3P3) “the justice question…..if you are spending resources on this you are not spending resources on something else within the mental health service. You might spend less on community psychiatric nurses for example because you just pay people these days and then you, you leave them to get on with it.”User Forum (FG15) (F15P2) “If there is going to be a money incentive just put it on their benefits without them thinking oh it’s because I’m, or if you’re gonna pay them pay them to actually, sorry, attend alternative therapies, alternative groups to socialise I mean, you see the money point it out on the betterment of their lifestyle and the life, the quality of life that they have instead of actually just encouraging them to come out once a month out the house take an injection and then just go and hide again for a month, actually give them the money to actually come and you know do a trip. Take your medication in Brighton (laughs) for example, no do you see so we should be focussing more on the life”Carers (FG16)(F16P3) “Personally I think if there is this money around, facilities to help improve people when they come out of hospital, to utilise nice facilities, you know, with well trained people would be much more beneficial, in every way, to help improve the others”Government agenda Carers (FG10)(F10P1) “It would have to be a very large sum of money to hook people and I imagine if this is a government idea then the amount of money they are thinking of is absolutely miniscule.”Consultants (FG17) (F17P2) “no they care about DLA, the two priorities of this government are public safety and DLA, incapacity benefit……..if government wants us to reduce the bill…”User Forum (FG15)(F15P2) “Did any of them, so three people got better then? so the government is seriously thinking about this then?”MDT (FG14) (F14P5, team manager) “…then actually we will be looking at CTOs, we will be doing it within a legal, under a legal statutory framework and I actually think the issue about paying people who are at this end of the scale, who’ve got severe mental illness, for me its problematic I d think its politically driven, I do think there is definitely a government agenda that’s my own sort of personal opinion…”(F14P6, nurse) “and I think the motivation is political and to save money and I’m not comfortable with it at all now”Service users (FG11)(F11P3) “erm can I ask you is it the government or the hospital that’s given us….is it the government that’s asked the hospital to do this survey? Or is it strictly from…straight from the hospital? So the government’s not behind this at all…”(drug companies)Carers (FG10)(F10P4) “I’m saying it’s for the good of the drugs company that we’re you know. Historically when we had our physical ailments and we went to the doctor we had our pills and we took our pills until we felt better and then we stopped taking pills. Now, more and more ailments require us to take pills for life and you know who, where’s the lead there, the lead is, are the drugs companies there…It’s the drug companies who are pushing erm drugs for life and I’m (laughs) so I’m a bit suspicious of drugs companies (laughs)”ThemeFocus groupQuoteProblems requiring policies and codes of practicePragmatics(how to be administered)Carers (FG22)(F22P2) “ how would you distribute it….on, you know, when they go to the GP for the depot?….I mean do you just hand over twenty quid or whatever, you know, and that money has got to come from somewhere they won’t….you know, the GPs aren’t  rich, are they? Any of the health centres are not”(impact on benefits)User Forum (FG15)(F15P5) “and I think it could effect things like benefits as well because erm on a wider scale it could be a thing where people will be, the government could end up saying we’re not gonna pay you your disability allowance unless you take your medication that’s been prescribed from you by a local authority rather than your GP whose got more case history about you so it could set an unhealthy trend for people”Voluntary organisations (FG6)(F6P6) “the final thought I had was erm impact on benefits I mean simply people who are on benefits, they ‘earn’ 10 or 15 quid a week or whatever and might it impact on any benefits they may be getting” (how long for)Non-executive directors (FG3)(F3P4) “I think that the timing issue is er an important one. At what point do you give the incentive. And it seems to me you give the incentive earlier even if you give it to them at all”(dependency on scheme)CMHT (FG23)(F23P2) “you’re making people more dependent onto the services when we are trying to get people to take responsibility for their own actions and consequences of their actions”Consultants (FG4)(F4P3)“I don’t know if you plan to take this away but, let’s just assume that you decide to stop giving the money after a while….what will then happen”Health economists (FG7)(F7P5) “and then what happens when or after the de…..let’s assume the depot works and you can…..you are placed in a situation of dependency where the individual has become dependent on payment for depot, the depot works so they don’t require depot anymore, what happens then?”Psychologists (FG9)(F9P2) “it seems to be promoting some sort for some kind of psychological sort of dependence on medicines and services as well, which is working contrary to promoting agency and self-advocacy that you get with psychology, we’re actually letting people down, so this is a quite a short term thing”(other practicalities)Carers (FG16)(F16P5) “when you say offer them money, how much money do you mean and how often would you be giving it to them?”Service users (FG11)(F11P5) “Who decides ehm how a severe mental illness before you start paying them…who decide…who made the, who decides that criteria for it?”Part of tool kitMDT (FG14)(F14P7) “I would say payment could be part of the care package but it shouldn’t be the focus”Nurses (FG8)(F8P3) “but it gives us an additional tool that we can use to build engagement continuously with the client, that would otherwise would have shut the door. And with that …all of that …all that elements comes in, reducing hospital admission, able to change people’s life for the better.”Consultants (FG4)(F4P5) “that its just one of sort of, one of the very many tools that the team should be working with and its not to be a sort of first, second line maybe a fourth line intervention”Last resort Non executive directors (FG3)(F3P1) “I think if there was a scenario where there was some incident where you’d tried everything and as a last resort you might consider that if you thought that the person was going to do harm to others”Nurses (FG8)(F8P3) “if we’ve tried all other forms of medication does it work for that particular client, like I said as a last resort if that client would come only by means of say we’ll give you the money, if that is the only way we can engage that client to accept his medication we will get that, yeah. But then every other method must have been used and seen that has failed”Service users (FG11) (F11P4)  “but I feel still that should be the end of the line rather than the first thing, there should be a lot of other steps being taken”Social workers (FG(FP)“it has to be the last resort, so…if there’s a financial incentive I’m sure an ASW would go for that than detainment under the mental health act”Voluntary organisations (FG6)(F6P6) “and the literature suggests that its, its after you’ve tried everything else you know its people who’ve remained non-compliant, who really do need their medications to stay stable when you have tried everything else so I think the assumption, the basic assumption is this is not a thing you offer at first point of contact you know you offer it as a last resort with people who are extremely non-compliant and very ill”.Easy optionNon-executive directors (FG3)(F3P4)“But I think underneath that before I even go further is that the question of morality and whether its simply an easy option to take eh instead of using all the other supports that are needed, er whether the family support, whether it is a full encouragement, whether it is additional discussions required with the service users and all other people around them em to encourage them to take their medication.”CMHT (FG23)(F23P4)“If you do this, go down that route, then people aren’t gonna address that issue, they’re just gonna go there for money and not look at the real issues behind why they are not taking the medication”“but it’s…it’s part of a care package as well in terms of your teaching people you know life skills, you know, healthy lifestyle, social skills and integration in to the community and then, you know, and fitting them in to the recovery model, it’s different rather just giving somebody money then they can do whatever they want with it, that may not be therapeutic at all”User Forum (FG15)(F15P1) “I think it’s also a lazy way and a quick way of saying oh lets deal with the problem.”Junior doctors (FG5) (F5P6) “...one of the reasons people do a lot of drug research, they try to get the top drug and then normally means trying to get a drug which is more effective and has less side effects. If loads of people are taking it anyway then….ehm…..you wouldn’t really need to try quite so hard to bring out a new medication, would you? So would people just sort of stick on the same old ones because people are gonna get £50 to take them anyway”Service users (FG11)(F11P7) “could you be just looking down like a one way street, sort of going you got these, take tablets, that will solve it, you are not actually thinking of a wider scope and all the other opportunities there are to take”Social workers (FG12)(F12P2) “But I think effectiveness of the treatment and their overall care and quality of life, is going to be sacrificed because they are gonna go onto a depot, because…its lot easier than spending that time and working with them to…to get that education in terms of taking the medication” (Why have they stopped the medication)Service users (FG21, FG11)(F21P2) “I would feel like I was selling out, often I don’t take medication because I….I feel it’s harming me and there are alternative approaches that I’d like to take to my mental health crisis, without having to ehm be involved with the….with the medical profession, ehm…”(F11P4) “also there are a lot of reasons why people don’t take it… and I’ve never been on like anti-psychotics so I’m not…I can’t talk from personal experience but I have seen people, you know, with side effects and that….and that does involve, you know, sort of the dribbling and stiffness and a weight gain etc, well we’ll just give you some money and yeah it will be fine.”Voluntary organisations (FG6)(F6P6) “….there are underlying reasons for non-compliance and they may be many and varied and what you’re doing with a payment is you’re not tackling the underlying reasons for non compliance. You’re sorting the problem possibly temporarily but you’re not tackling the underlying… and if erm you know you are distracting if you like attention away from the need for services to tackle the underlying problem rather than stick a plaster over it”CMHT (FG23)(F23P4) “If you do this, go down that route, then people aren’t gonna address that issue, they’re just gonna go there for money and not look at the real issues behind why they are not taking the medication, cos there are all sort of reasons why people don’t take medication, you know, having a depot medic…a depot, you know putting a substance into your body that’s gonna stay and have an effect over a long period of time, there’s a massive decision, even just having a needle stuck in your body is a huge thing to ask somebody to do, isn’t it? I think paying people who are vulnerable anyway, who may have been on benefits and vulnerable anyway, I have strong ethical concerns about that”ThemeFocus groupQuoteChallenges for evidence and experience Effectiveness(would it work?)Carers (FG10, FG16)(F10P1) “(talking about mentally ill son) ….he does nothing so the idea of outings and treats wouldn’t work either. He has no need of money, sadly. He doesn’t want to spend money, he wants nothing apart from to stop feeling so ghastly, so it wouldn’t work with him”(F16P1) “but if you’re, when you are very ill or when you have a breakdown you don’t think of money really…..”User Forum (FG15)(F15P4) “It doesn’t really make sense if everything else has been tried what’s to say that paying them is gonna make them take the medication anyway, it just, what are, so you give them money but that doesn’t you know….Why do they think that this is gonna actually work if everything else has been tried”Voluntary organisations (FG6)(F6P2) “I think what you were saying before, if someone’s life is so chaotic then an extra bit of money isn’t really gonna make that much odds anyway, I kind of don’t see it as actually a particularly good solution. I don’t think it’s a solution at all”(need of further research)Consultants (FG17)(F17P6) “I’ve often thought that it would seem to me to be something which we should be able to do, because of the immense potential advantage that might accrue in ways that people haven’t thought of. That’s worth studying”(F17P6) “but they would be more able, if they stay well, the longer they stay well the more able they are to engage in things, like the work skills group, so it….if the findings are that this enhances adherence it seems to me to be that is very worthwhile, and that’s ethical as well, keeping people well seems to be, you know, ethically positive duty of the doctor yeah”Non-executive directors (FG3)(F3P4) “My point is that if I was convinced that it was effective and actually achieving the result it is intended to do which is the consistent, a very important word for me, the consistent taking of that medication, then I could be persuaded that it might be right” (F3P2) “… where is the evidence that there would be any different outcome for the individual or the community by paying this individual to take their medication. And if there is, then if there is evidence to say that that would work then why on earth isn’t that been taken into account at a much earlier stage in planning the care package and the support more generally”Nurses (FG8)(F8P1) “I guess if this scheme was proved to work I would do it, even though I’m against in my own views, you know hard cash but if someone said to me “yeah half of your clients are actually gonna stay out of hospital if you give them 10 pound cash” even if my views were “I don’t like this”, I would actually do it”Perverse incentiveCMHT (FG23)(F23P4) “yeah you know, could you though potentially get people stopping the medication who are, usually would take it so that they could get possibly get the money for taking it, add to another issue, potential issue”Health economists (FG7)(F7P3) “well, as soon as you go down that line you’re throwing me…..ehm…..closer to the real problem I have which is I don’t think you can only pay some people because as soon as you do that, you are encouraging other people to behave in the same way”Nurses (FG8)(F8P4) “I just can’t in practice see how you could set up a scheme without creating all sorts of perverse disincentives around it, people who would feel discouraged from, obviously you work on trying to get people’s insight in to their need for medication and their seeing it as beneficial to them and  I can’t see how you could set up a scheme without actually encouraging people to claim that they were worse than they were”  Service users (FG11)(F11P4) “….if like offering payment for medication you might then have this sort of counter effect of….encouraging people not to take their medication, on the grounds that they know of people who have refused medication, who then get payment, people aren’t stupid”Alteration of relationship dynamics (between clinician and patient)Consultants (FG17)(F17P6) “but in terms…in terms of the therapeutic relationship it seems to me that most of the time we have to tell people what to do against their will, in ways they don’t understand and impose them on them and spend out time signing forms, imposing restrictions on their freedom and restrictions on their physical state and making them have medication that gives them side effects, that make their willies shrivel, alright so actually most of what we have to do to them while trying to maintain a therapeutic relationship is perceived as negative, so if as part of that therapeutic relationship there could be some positive things as well, hey you get something out of this, not just punishment and control. That potentially could alter the therapeutic relationship in a beneficial way, that actually…it makes concrete the social benefits that we try to explain to them exist for staying well”Psychologists (FG9)(F9P3) “the issue of paying people to take drugs is a kind of problematic, in terms of how it might interfere with that kind of relationship that you might have with your service users, kind of and what the mean, and how do necessarily those two things together”(F9P1) “…I think that comes into the bargaining thing about, you know, it can be construed as “I just want to have an easy life, I want to sedate you so you’re not gonna be at risk to yourself or other people, and I’m prepared to pay you for that” (F9P3-hm), and that that can affect the therapeutic relationship”Social workers (FG12)(F12P1) “it’s about having a collaborative relationship, not one having more control over the other, it’s meant to be an equal therapeutic relationship so…I just don’t agree with it at all, I can see all kind of erm difficulties when you start offering people money”(between patient and medication)User Forum (FG15)(F15P5) “but you might have a situation where people who have got this serious mental health issues, they’re actually correlating taking their medication with paying their bills or paying the council tax and having money in their pocket for food and lunch and it will almost be like taking their medication will be kind of like a lifestyle choice rather than an actual necessity to help improve their wellbeing cos if it’s strictly a financial monetary value, that their, that’s being placed on whether they take their medication or not erm it, I think it’d be quite easy for them to misinterpret why they’re taking their medication in the first place or why they’re taking a particular medication in the first place”Junior doctors (FG5)(F5P4) “The second thing is it persuades the patient that there is something wrong with this treatment that actually it’s a bit like the polio vaccine you know you’re not gonna take it unless it’s on a sugar lump”Service users (FG19)(F19P2) “for some reason it doesn’t sit well with me…..er…..what does that say about me? What does that say about me if I need to take money to….receive money to take my medication? What does that say about me and my…to my relationship between myself and my drugs?”ThemeFocus groupQuoteInherent dilemmas Coercion(Behavioural change mechanism)Consultants (FG17)(F17P6)“well that’s what I mean cos the alternative…oh yeah if what you are saying is well let’s pay…let’s not pay them for medication, let’s pay them to keep their flat clean and to keep their personal hygiene clean, that really is an imposition of a particular social style and structure, when is a flat clean? I quite agree with you that is disgraceful”Voluntary organisations (FG6)(F6P2) “I just can’t imagine how you know because people do live on very small amounts of money and why on earth would anyone behave themse…, behave themselves in inverted commas and take stuff that they don’t want to take because they just know that people will get on their case”(money as an incentive for poor)Junior doctors (FG5)(F5P3) “you don’t want to take this medication, you are a grown woman and you don’t want to take the medication but I’m gonna play to something that you cannot refuse because you really need this £50 so….”Psychologists (FG9)(F9P1) “I think there is also an ethical sort of paradox as well, that it’s side stepping the whole issue that a lot of mental health problems are actually linked to economic deprivation, so it’s sort of almost putting a bit of salt into the wound to say “well, I know you’re strapped for cash, and that’s probably adding to your problems, I’ll use this as a way of making you comply to medication” which isn’t really addressing some of the social issues, that ehm are contributing to your problems”Social workers (FG12)(F12P2) “you can set up an expectation that people are paid to take medication, and I think it would exploit the most vulnerable people, because pe…..the cost implication is who do you pay….if someone has got plenty of money, then offering them 5, 10, 15, 20 pound is not gonna make any difference to them” (vouchers preferable)Consultants (FG17)(F17P6) “…obviously we need to be careful as to how that’s done, and maybe vouchers or take off their electricity bill or whatever it might be, might be another way of doing it rather than actually cash in hand, so it could be an incentive via a benefit whatever that might be”Nurses (FG8)(F8P1) “I’d feel more comfortable maybe if it was food vouchers”(might take despite side effects)CMHT (FG23) (F23P4) “cos they give side effects and then you are asking to be paying people to take that there’s some ethical concerns around that you know, you may….  people may take medication that’s giving them severe side effects if they want the money for instance”Consultants (FG4)(F4P7) “influencing consent, putting pressure to consent at the individual level that is ….the individual patients get some money an incentive for that…for me is unethical because that patient may not benefit from that medication and we know that many patients do not benefit from that medication and even in the …..even in the……ehm…… situation where there is historical response to medication…that is not an absolute predictor of future response to medication.”Social workers (FG12)(F12P3) “I’m afraid also clients that will agree to be paid to take medication, would they be honest enough to tell us the side effects because the ones that want the money, just for the money, because some people will just be for the money, are they going to be telling us there are side effects that they experience on a day to day basis? Because some will be frightened to say, you know I’m gonna lose out if I tell my social worker that or my nurse that I’m experiencing these side effects, you know, ehm, I don’t know for various reasons they may not want to tell us”(reward, compensation)Carers (FG10) (F10P1) “He said the second thing is the only people that get paid to take medication are people who are part of trials and they’re paid as compensation because of the potential dangers so that couldn’t be a good idea, and I thought that’s a very good point (laughs) bearing in mind that a lot of people concerned would be paranoid anyway”(autonomy)Consultants (FG4)(F4P1) “I see money as paradoxically more liberating and erm enabling greater autonomy but ultimately if the person doesn’t want the money they will just not take it” “but the reality is that there is always a choice and that’s the bottom line, that the patient or service user does have a choice. They can choose to refuse and to, what we found was that those who are really really unwell, whether you offer them anything they will say no”Service users (FG19)(F19P4) “but if the depot is causing me side effects I still don’t want it, see, I still would refuse so I’m one that would refuse and I wouldn’t need that money because of the side effects I have to be counteracting” (long term responsibilities) Nurses (FG8) (F8P5) “what if they consented just because of the money and then they develop something awful the same way that you know….some people on olanzapine developed diabetes, where…where...where do we stand? We’ve paid them to take that….but it’s not a drug trial”Psychologists (FG9)(F9P4) “…..the ethics, of you know paying people to give them drugs, which actually is likely to lead to their eventual death, I think is (laughs), you know, is highly problematic. And but these things aren’t talked about, you know, these things are, you know, the drugs are sort of seen as kind of fairly inert or beneficial, kind of substances, you know which…you know, the idea that they’re medications as opposed to you know drugs with a range of some, you know, some of positive but also kind of negative effects”(Other structures of coercion)Consultants (FG17)(F17P4)“I mean F17P1 is right, we force treatments on people, we only do it when they lack the capacity to consent for it, and when I’m in a situation where I feel as though I’m actually coercing someone erm who is  saying “I don’t want to be sectioned doctor, I will agree to come in, I’ll take my medication” but you know they don’t want to I’ll make a recommendation to the mental health act because I think they lack capacity and I feel as though I’m coercing them which is something that professionally, morally, ethically, I feel completely opposed to as a doctor”MDT (FG14)(F14P5) “for me the only thing I will ever feel comfortable with is using the CTOs and that is just my moral professional and ethical position and in terms of protecting the public we can do that if we use CTOs appropriately and if we use the mental health act appropriately there’s enough legislation”Nurses (FG8)(F8P1) “I also think on issues of erm insight and relapse prevention, none of my clients, to be honest, have got any insight, but what they do realise is that if they don’t take an injection they end up in hospital and that’s the best I can hope for in terms of insight and relapse prevention. And in order to get to that level they’ve had to have not taken their depot and become ill, numerous amounts of times. Ok, they don’t sit announcing “I want my depot because I’ve got schizophrenia” but they will say “I want my depot because when I come off I lose my house, I lose my benefits” as well”Service users (FG19)(F19P1) “what works with me, having….I always make sure I take my medication there is no way do I wanna end up in hospital, and that is more effective for me than giving me money, you know? Being put back in to hospital I think it’s the worst thing that could happen, you know, and ehm and taking my medication is a must, I know everybody’s views different in that way, but I think being in hospital…it’s more effective, you know. Who wants to be in hospital, you know?”Team managers (FG13) (F13P1) “you take someone into hospital on section, there’s a very clear process, you’ve got a process where somebody can appeal against that, that they’ve got rights it goes through a whole set procedure, there is no appeal if someone’s freely coming in and saying “yeah give me a tenner and I’ll take my medication, depot whatever”(methods of covert coercion)Nurses (FG8)(F8P3) “if by the time we’ve tried all these things we’ve mentioned, like in my team here we give out, we do give out, we give food to clients as a way of engaging them, we charge the electricity, we charge the gas, in some cases when we know clients are desperate and they haven’t got money to do things, by asking them to come in that we will charge ….for example, clients that we know are drug or illicit drug users we don’t give them the money to go charge their electricity, we’d rather do it for them. But asking them to come here that we follow them to the shop and do it, we’re promoting engagement.”Team managers (FG13)(F13P2) “in assertive outreach you have to come out with whatever means necessary to get people engaged sometimes, and we found ourselves having to ehm take people for lunch for example, take people on trips that in CMHTs you’d never dream of doing, mainly because of resources and time and money, but we had those resources of….we’re….I was already doing quite a lot of that but I’d not though about giving money as such, but in a way ehm I think this is where we’re heading to, because I would say to someone you know “come in to….come in for your depot and after that we’ll go for ehm….a pint in the pub or something like that, well I wont drink because I’m still at work but you can have…” you know, things like that, so it was…moving in that direction I think.”Equity - Justice CMHT (FG23)(F23P2) “I think that’s the big thing, how do you justify that two people, very similar circumstances, one will be entitled to money the other one doesn’t.”Health economists (FG7) (F7P5) “And I do believe that there are some equality issues there, because to the extent that you are suggesting equal access-equal need, or equal need-equal access whichever way you want to look at it, then you are suggesting that there are some groups which wouldn’t benefit from this type or may benefit on a greater scale than some other groups, I think if it is that you agree to do such a thing then it’s…..there are inequities in the system and it means perhaps putting out even though the absolute amount seems small in aggregate, in terms of the budget implications they may be large implications on the budget given the degree of differentiation that you need to…to assume”  Non-executive directors (FG3)(F3P3) “but also what about the ethics of that? You know, you’re gonna pay one person just because he’s very, very difficult. But his next door neighbour who is merrily taking the depot, going along each time, doesn’t get paid. I mean you can’t justify....”Service users (FG11) (F11P4) “but then you can imagine you’ve got a group of service users and some of them are being paid to take the medication and some aren’t, there’s be mutiny”
